DrugTargetWorld: A Synthetic Biobank for Training and Benchmarking AI Scientists
An open benchmark for training and evaluating AI agents on end-to-end, biobank-based drug target discovery.
Leaderboard
| # | Model | Serving | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | Opus 5 | 39.98 | 14.80 | 7.19 | 13.05 | 86.64 | $4.14 | API |
| 2 | GPT-5.6 Sol | 35.38 | 15.81 | 3.16 | 13.00 | 83.19 | $2.02 | API |
| 3 | Sonnet 5 | 21.33 | 10.24 | 1.16 | 6.96 | 83.88 | $1.47 | API |
| 4 | Haiku 4.5 | 12.92 | 5.27 | 0.21 | 5.91 | 75.00 | $0.26 | API |
| 5 | gpt-oss-20b | 7.41 | 2.94 | 0.68 | 3.43 | 75.00 | $0.07 | GPU |
| 6 | Qwen3-Coder-30B | 5.90 | 3.26 | 0.14 | 1.94 | 75.00 | $0.05 | GPU |
| 7 | GLM-4-32B | 1.46 | 1.12 | 0.08 | 0.25 | 25.00 | $0.20 | GPU |
| 8 | Qwen3-8B | 1.31 | 0.70 | 0.39 | 0.22 | 30.71 | $0.22 | GPU |
| 9 | Devstral-Small | 0.81 | 0.75 | 0.06 | 0.00 | 15.00 | $0.20 | GPU |
Mean score across 20 worlds Ć 3 budget conditions, one replicate each. Scores are out of 100; measured ceiling = 85.5.
Qwen3-8B and GLM-4-32B ran a reduced 8,000-token output budget and are not a like-for-like comparison.
Disease states
Each synthetic world expresses hidden disease biology through participant-level medical data.
Dilated cavity with visibly reduced contraction across the cine loop.
03 Environment
How it works
Biobank
Genetics, omics, imaging, ECG, EHR.
Phenotype
Segment the myocardium from raw arrays, engineer features, fit a model against a proxy outcome.
Causal targets
Screen the proteome, instrument it genetically, separate drivers from decoys.
Experiments
Spend a finite research budget.
Submission
Nominate targets and therapeutic direction.
world_07/
āā genotypes.vcf.gz
āā proteomics.parquet
āā transcriptomics.parquet
āā metabolomics.parquet
āā covariates.parquet
āā ecg_features.parquet
āā coronary_ct.parquet
āā ehr_diagnoses.parquet
āā mortality.parquet
āā mace_events.parquet
āā targetability.parquet
āā imaging/
āā imaging_visit2/The agent receives the files, writes Python, and chooses analyses and experiments over 30 turns.
04 Method
Hidden causal worlds
Each world is procedurally generated from a sealed structural causal model linking genetics, molecular measurements, hidden disease state, observable phenotypes, and intervention outcomes.
The identity and number of causal molecular drivers are hidden from the agent.
Analyses and experiments are chosen against accumulated evidence and the remaining budget.
T1 Confounding Ā· T2 Reverse causation Ā· T3 Selection / collider Ā· T4 Causal non-identifiability Ā· T5 Batch effects Ā· T6 Benign remodeling Ā· T7 Instrument pleiotropy Ā· T8 Surrogate-outcome discordance Ā· T9 Assay unit mixing Ā· A9 Slow effect